Elanco Acquires Bayer’s Animal Health Business
Davis Polk is advising Duff & Phelps as financial adviser to the Board of Directors of Elanco Animal Health Incorporated in connection with its approximately $7.6 billion acquisition of Bayer AG’s animal health business. The transaction is expected to close in mid-2020, subject to regulatory approvals and other customary closing conditions.
Elanco is a global animal health company that develops products and knowledge services to prevent and treat disease in food, animals and pets in more than 90 countries. Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population.
The Davis Polk corporate team includes partner William L. Taylor and associate Jason P. Thompson. All members of the Davis Polk team are based in the New York office.